Browse Title Index
Issue Title
Vol 57, No 6 (2023) Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice Details
Bartosz Karaszewski
Vol 54, No 4 (2020) Reply to the Letter to the Editors: DBS patient with diagnosed Non-Hodgkin’s lymphoma: is radiation therapy safe? Details   PDF
Michał J. Schinwelski, Jarosław Dulski, Wojciech Łuczak, Witold Libionka, Tomasz Mandat, Jarosław Sławek
Vol 56, No 3 (2022) Response relating to the article 'Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes' Details
Pavel Štourač, Jana Bednářová, Zbyšek Pavelek, Martin Vališ
Vol 57, No 3 (2023) Response to Letter to the Editors regarding article entitled ‘Left ventricular non-compaction cardiomyopathy and ischaemic stroke’ Details
Cătălina Elena Bistriceanu, Florentina Anca Danciu, Dan Iulian Cuciureanu
Vol 57, No 3 (2023) Response to Letter to the Editors regarding article entitled ‘Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients’ Details
Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, Agnieszka Słowik, Marcin Wnuk, Leszek Drabik
Vol 57, No 2 (2023) Response to the Letter to the Editors on the article reviewing the complex subject of ‘Impact of SARS-CoV-2 on the nervous system’ Details   PDF   HTML
Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska
Vol 57, No 4 (2023) Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’ Details
Radosław Piekarski, Anna Roszmann, Jarosław Dulski, Jarosław Sławek
Vol 56, No 1 (2022) Response to ‘Neuro-COVID due to the response against the virus’ Letter Details
Jolanta Bratosiewicz-Wąsik
Vol 57, No 5 (2023) Response to ‘Neurologists should retain diagnostic and therapeutic management of migraines’ Details
Magdalena Boczarska-Jedynak
Vol 54, No 3 (2020) Response to “Does amantadine have a protective effect against COVID-19?” Details   PDF
Philip W. Tipton, Zbigniew K. Wszolek
Vol 57, No 6 (2023) Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience Abstract
Ewa Włodarczyk, Katarzyna Sawczyńska, Paweł Wrona, Agnieszka Słowik
Vol 54, No 2 (2020) Risk factors for death by acute ischaemic stroke in patients from West-Pomerania, Poland Abstract   PDF
Paweł Wańkowicz, Monika Gołąb-Janowska, Przemysław Nowacki
Vol 57, No 5 (2023) Risk factors for dementia in Parkinson’s Disease — the overuse of anticholinergic drugs Abstract
Jakub J. Malkiewicz, Amadeusz G. Kasprzyk, Damian Waksmundzki, Julia Węgrzynek, Tomasz Chmiela, Joanna Siuda
Vol 56, No 5 (2022) Risk factors for infarct growth and haemorrhagic or oedematous complications after endovascular treatment — a literature review Abstract
Izabella Tomaszewska-Lampart, Marcin Wiącek, Halina Bartosik-Psujek
Vol 48, No 5 (2014) Risk factors for re-bleeding of aneurysmal subarachnoid hemorrhage: Meta-analysis of observational studies Abstract   PDF
Gobran Taha Ahmed Alfotih, FangCheng Li, XinKe Xu, ShangYi Zhang
391 - 405 of 540 Items <<   <   22 23 24 25 26 27 28 29 30 31   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl